The immunomodulatory effects of statins in community-acquired pneumonia: A systematic review - 21/06/13
, C.H. van Werkhoven a, J.J. Oosterheert bSummary |
Objective |
To evaluate the potential immunomodulatory effects of statins in community-acquired pneumonia.
Methods |
We performed a systematic review of available literature on experimental and clinical studies. We used a PubMed/MEDLINE and EMBASE search to identify potential articles.
Results |
We identified 34 original studies, 17 experimental and 17 clinical studies, published up to March 2013.
Conclusions |
Statins attenuated pulmonary inflammation by modulating neutrophil function, by reducing cytokine expression and release, and by protecting against disruption of pulmonary integrity. However, additional experimental studies are needed to fully elucidate the exact mechanisms. Several clinical studies suggested a decreased risk of CAP or a reduction in mortality due to CAP for current statin users, but the mostly observational design of these studies hampers the interpretation of their results. Therefore, appropriately designed studies, such as randomised controlled trials, are required to demonstrate the usefulness of statins in the prevention and treatment of CAP.
Le texte complet de cet article est disponible en PDF.Keywords : Community-acquired infections, Pneumonia, Statins, HMG-CoA, Immunomodulation, Review, Systematic
Plan
Vol 67 - N° 2
P. 93-101 - août 2013 Retour au numéro
Article précédent
- Editorial Board
- Risk score for identifying adults with CSF pleocytosis and negative CSF Gram stain at low risk for an urgent treatable cause
- Rodrigo Hasbun, Merijn Bijlsma, Matthijs C. Brouwer, Nabil Khoury, Christiane M. Hadi, Arie van der Ende, Susan H. Wootton, Lucrecia Salazar, Md Monir Hossain, Mark Beilke, Diederik van de Beek
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?